Transesophageal Endoscopic Ultrasound With Bronchoscope‐Guided Fine‐Needle Aspiration for Tissue Diagnosis of Pleural Malignancy in a Patient With Respiratory Compromise
Thoracic Cancer · 2026-11 · 17 (21)
DOI: 10.1111/1759-7714.70416 ↗Abstract
ABSTRACT Histologic confirmation is essential in suspected pleural malignancy, particularly for subtype classification and molecular profiling. However, conventional diagnostic approaches, including thoracoscopic, percutaneous, and airway‐based bronchoscopic biopsy, may be difficult or high‐risk in patients with severe respiratory compromise or poor pulmonary reserve. Endoscopic ultrasound with bronchoscope‐guided fine‐needle aspiration (EUS‐B‐FNA) is not a standard diagnostic modality for pleural disease, and its role in sampling pleural lesions remains insufficiently characterized. A 71‐year‐old man with severe chronic obstructive pulmonary disease and a history of pneumothorax presented with progressive dyspnea. Chest computed tomography showed severe emphysema, left pleural effusion, and multifocal nodular pleural thickening suspicious for pleural malignancy. Pleural fluid cytology revealed malignant cells; however, tissue biopsy was required for definitive histologic classification and molecular testing. Despite pleural drainage, the patient remained dependent on high‐flow nasal cannula (HFNC) support because of persistent hypoxemia and hypercapnia. Conventional diagnostic procedures, including bronchoscopic biopsy, transthoracic needle biopsy, and thoracoscopic biopsy, were considered difficult or high‐risk because of severe bullous emphysema, marked dyspnea, respiratory failure, and the unavailability of medical thoracoscopy at our institution. As the pleural lesion was adjacent to the esophagus, EUS‐B‐FNA was performed under HFNC support. Histopathology confirmed poorly differentiated lung adenocarcinoma. The patient was ultimately diagnosed with stage IV lung adenocarcinoma with pleural metastasis. Transesophageal EUS‐B‐FNA may provide an alternative route for tissue acquisition in selected patients with suspected pleural malignancy when conventional biopsy is difficult or high‐risk and pleural lesions are anatomically accessible from the esophagus.
EUVIMED